UK Markets close in 5 hrs 24 mins

JNJ Jan 2021 105.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
As of 10:10AM EDT. Market open.
Full screen
Previous close1.0000
Open1.0600
Bid0.0000
Ask0.0000
Strike105.00
Expiry date2021-01-15
Day's range1.0000 - 1.0600
Contract rangeN/A
Volume2
Open interestN/A
  • Mexico to trial China, U.S. COVID-19 vaccines, may produce some
    Reuters

    Mexico to trial China, U.S. COVID-19 vaccines, may produce some

    Mexico aims to conduct late-stage clinical trials for COVID-19 vaccines in development by U.S. and Chinese companies, two of which might base some of their vaccine production in the country, the foreign ministry said on Tuesday. Mexico has signed memorandums of understanding with Johnson & Johnson, along with Chinese companies CanSino Biologics Inc and Walvax Biotechnology Co Ltd, Foreign Minister Marcelo Ebrard said at a news conference.

  • J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trials
    Reuters

    J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trials

    Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said. J&J kicked off in July early-stage human safety trials for its potential COVID-19 vaccine after releasing details of a study in monkeys that showed its best-performing candidate offered strong protection in a single dose. Large-scale trials are set to start by the beginning of October and J&J aims to have results on the vaccine's efficacy between the end of this year and mid-2021, Johan Van Hoof, head of vaccines at Janssen, told Reuters on Tuesday in a telephone interview.

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more